secwatch.observer — SEC 8-K summary
======================================

Issuer:     PETMED EXPRESS INC (PETS)
CIK:        0001040130
Form:       8-K
Filed at:   2026-08-13T20:17:02+00:00
Accession:  0001040130-26-000040
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetMed Express Q1 net sales down 19.9% to $41.0M; net loss narrows to $6.1M
---------------------------------------------------------------------------

- Net sales $41.0M vs $51.2M prior year, down 19.9% on lower prescription sales and reduced promotional usage.
- Net loss $6.1M ($0.28/share) vs $34.2M ($1.65/share) loss prior year; improvement from no goodwill/trade name impairment.
- Adjusted EBITDA $(3.4)M vs $(2.7)M prior year.
- Acquired 70,000 new customers; cost per new customer down 15% YoY; G&A down ~14%.
- Completed SAP ERP rollout; sale-leaseback transaction to strengthen balance sheet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/0001040130-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1040130/000104013026000040/pets-20260813.htm
  HTML page:      https://secwatch.observer/filing/0001040130-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer